Transverse myelitis screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Transverse myelitis}} {{CMG}}; {{AE}} {{MMJ}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR Accordin..." |
No edit summary |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for transverse myelitis. | ||
==References== | ==References== |
Latest revision as of 07:37, 21 April 2020
Transverse myelitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Transverse myelitis screening On the Web |
American Roentgen Ray Society Images of Transverse myelitis screening |
Risk calculators and risk factors for Transverse myelitis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for transverse myelitis.